Trial of XELOX Followed by Radiation Combined With Carboplatin and RAD001 for Esophageal Cancer

NCT01490749 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer
Neoplasms, Esophageal

Interventions

DRUG: RAD001
DRUG: XELOX
DRUG: Carboplatin
RADIATION: Radiation

Sponsor

Emory University

Collaborators

[object Object]